ARGX

argenx SE (ARGX)

Last Price$651.40.3%
Market Cap$39.4B
LTM FCF to Net Income
103.2%
5Y avg
60.4%
Biotechnology industry median
83.9%
Stock quality & Intrinsic value
6/10
(0.8%) overvalued

argenx SE FCF to Net Income

Annual
Quarterly
LTM
Industry median
Company stand-alone
ARGX
Healthcare
Crunching data... Almost there!
Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
FCF to Net Income
0.0%
91.0%
84.3%
98.3%
50.5%
90.8%
(45.5%)
160.9%
66.6%
(52.0%)
84.0%
208.8%
134.2%
109.2%
ARGX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ARGX and see if it's the right time to invest.
Dive in

argenx SE (ARGX) FCF to Net Income comparison analysis

Crunching data... Almost there!

ARGX key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is argenx SE's FCF to Net Income?

As of today, Microsoft Corp's last 12-month FCF to Net Income is 103.2%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for argenx SE have been 92.1% over the past three years, and 63.4% over the past five years.

2) Is argenx SE's FCF to Net Income Good?

As of today, argenx SE's FCF to Net Income is 103.2%, which is higher than industry median of 83.9%. It indicates that argenx SE's FCF to Net Income is Good.

3) How does argenx SE's FCF to Net Income compare to its peers?

As of today, argenx SE's FCF to Net Income is 103.2%, which is higher than peer median of 76.7%. The list of peers includes VRTX, MRNA, GMAB, BGNE, UTHR, REGN, NVO, INCY, ALNY, BNTX.